Activity of Azacitidine and Venetoclax Compared to Other Therapies in Adults with Refractory or Relapsed Acute Myeloid Leukemia, a Retrospective Study

被引：0
|
作者：
Pelland, Andree-Anne [1 ]
Savard, Xavier [1 ]
Barabe, Frederic [1 ]
Laroche, Vincent [1 ]
Munger, Michael [1 ]
Gallagher, Genevieve [1 ]
Marcoux, Nicolas [1 ]
Cantin, Guy [1 ]
Chenard-Poirier, Maxime [1 ]
Delage, Robert [1 ]
Lalancette, Marc [1 ]
Lemieux, Christopher [1 ]
机构：
[1] Univ Laval, Ctr Integre Cancerol, CHU Quebec, Quebec City, PQ, Canada
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170223
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3304 / 3305
页数：2
相关论文
共 50 条
  • [1] Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study
    Pelland, Andree-Anne
    Deschenes-Simard, Xavier
    Savard, Xavier
    Giguere, Philippe
    Spillane, David
    Barabe, Frederic
    Laroche, Vincent
    Munger, Michael
    Gallagher, Genevieve
    Marcoux, Nicolas
    Cantin, Guy
    Chenard-Poirier, Maxime
    Delage, Robert
    Lalancette, Marc
    Veilleux, Olivier
    Assouline, Sarit E.
    Lemieux, Christopher
    LEUKEMIA & LYMPHOMA, 2024, 65 (13) : 1974 - 1982
  • [2] Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
    Bouligny I.M.
    Murray G.
    Doyel M.
    Patel T.
    Boron J.
    Tran V.
    Gor J.
    Hang Y.
    Alnimer Y.
    Ho T.
    Zacholski K.
    Venn C.
    Wages N.A.
    Grant S.
    Maher K.R.
    Medical Oncology, 41 (3)
  • [3] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
  • [4] A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia
    Murthy, Guru Subramanian Guru
    Saliba, Antoine N.
    Szabo, Aniko
    Harrington, Alexandra
    Abedin, Sameem
    Carlson, Karen
    Michaelis, Laura
    Runaas, Lyndsey
    Baim, Arielle
    Hinman, Alex
    Maldonado-Schmidt, Sonia
    Venkatachalam, Annapoorna
    Flatten, Karen S.
    Peterson, Kevin L.
    Schneider, Paula A.
    Litzow, Mark
    Kaufmann, Scott H.
    Atallah, Ehab
    HAEMATOLOGICA, 2024, 109 (09) : 2864 - 2872
  • [5] Prediction of Volasertib Sensitivity in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax Plus Azacitidine
    Patil, Lokesh
    Gu, Christine J.
    Tognon, Cristina
    Long, Nicola
    Johnson, Kara
    Fischer, Melissa A.
    Ball, Somedeb
    Savona, Michael R.
    Leonardi, Chris
    Wagner, Joseph
    Michelson, Glenn
    Lacher, Markus D.
    BLOOD, 2024, 144 : 5818 - 5819
  • [6] Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia
    Walker, Alison R.
    Klisovic, Rebecca B.
    Garzon, Ramiro
    Schaaf, Larry J.
    Humphries, Kristina
    Devine, Steven M.
    Byrd, John C.
    Grever, Michael R.
    Marcucci, Guido
    Blum, William
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1304 - 1308
  • [7] Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Linkesch, Werner
    Pfeilstoecker, Michael
    Autzinger, Eva Maria
    Tinchon, Christoph
    Sliwa, Thamer
    Lang, Alois
    Sperr, Wolfgang R.
    Geissler, Dietmar
    Krippl, Peter
    Voskova, Daniela
    Rossmann, Dieter H.
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Theiler, Georg
    Valent, Peter
    Eckmuellner, Otto
    Greil, Richard
    BLOOD, 2014, 124 (21)
  • [8] Venetoclax in Combination with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia Is Comparable to Alternative Regimens
    Miller, Jenn
    Shannon, Lindsey
    Finch, Amanda
    Altman, Jessica K.
    Wojenski, Daniel
    BLOOD, 2020, 136
  • [9] Outcomes of Adults Treated with a Hypomethylating Agent Plus Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia: A Multicenter Retrospective Study
    Geramita, Emily
    Wang, Hong
    Bastacky, Melissa
    Cohen, Jessica
    Shallis, Rory Michael
    Badar, Talha
    Litzow, Mark R.
    Im, Annie
    BLOOD, 2022, 140 : 6187 - 6188
  • [10] Venetoclax-Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC-DATAML-MSKCC Retrospective Study
    Petit, Cassandre
    Higue, Jules
    Acheaibi, Ziyad
    Gilhodes, Julia
    Hospital, Marie-Anne
    Devillier, Raynier
    Bewersdorf, Jan
    Goldberg, Aaron D.
    Pigneux, Arnaud
    Vey, Norbert
    Recher, Christian
    Stahl, Maximilian
    Bertoli, Sarah
    Dumas, Pierre-Yves
    Garciaz, Sylvain
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (05) : 906 - 908
12345